AVH.AX

AVITA Medical, Inc.
ASXAUDEQUITY DELAYED
Last price
2.79
▼ 0.03 (1.06%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2.79
Prev close
2.82
Day high
2.80
Day low
2.72
Volume
562.09K
Market cap
P/E (TTM)
52W range
1.00 – 2.86

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+26.24% +27.6%
1M
+103.65% +99.9%
3M
+118.82% +115.7%
6M
+118.82% +107.8%
YTD
+165.71% +153.4%
1Y
+88.51% +68.5%
3Y
-43.18% -117.3%
5Y
-47.95%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on AVH.AX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $71.61M$64.25M$50.14M$34.42M +11.5%
Operating revenue $71.61M$64.25M$50.14M$34.42M +11.5%
Cost of revenue $12.79M$9.09M$7.78M$6.04M +40.7%
Gross profit $58.82M$55.16M$42.36M$28.38M +6.6%
Research & development $20.84M$20.36M$20.82M$13.86M +2.4%
Selling, general & admin $80.51M$91.39M$65.63M$45.24M -11.9%
Total operating expense $101.35M$111.75M$85.02M$55.88M -9.3%
Operating income -$42.53M-$56.59M-$42.66M-$27.50M +24.8%
Net interest income -$5.00M-$5.36M-$1.14M-$16.00K +6.7%
Pre-tax income -$48.58M-$61.79M-$35.31M-$26.63M +21.4%
Tax provision $11.00K$54.00K$66.00K$36.00K -79.6%
Net income -$48.59M-$61.84M-$35.38M-$26.66M +21.4%
Net income to common -$48.59M-$61.84M-$35.38M-$26.66M +21.4%
Basic EPS -0.35-0.48-0.28-0.21 +27.2%
Diluted EPS -0.35-0.48-0.28-0.21 +27.2%
EBIT -$43.57M-$56.43M-$34.17M-$26.61M +22.8%
EBITDA -$41.23M-$55.30M-$33.54M-$26.05M +25.5%
Basic shares 139.30M129.42M126.66M125.00M +7.6%
Diluted shares 139.30M129.42M126.66M125.00M +7.6%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
2.36
+18.02% from price
SMA 20
1.85
+51.01% from price
SMA 50
1.48
+88.21% from price
SMA 100
1.35
+106.57% from price
SMA 200
1.25
+122.34% from price
EMA 12
2.27
+23.10% from price
EMA 26
1.91
+46.39% from price
EMA 50
1.64
+69.69% from price
RSI (14)
84.3
Overbought
MACD (12,26,9)
0.36
Hist 0.11
ATR (14)
0.17
6.13% of price
Realised vol 30D
124.0%
Annualised
Bollinger upper
2.96
20, 2σ
Bollinger lower
0.74
20, 2σ
50 / 200 cross
Golden
1.48 vs 1.25
Trend bias
Above 200
+122.34%

Options chain

Account required
ExpirySpot 2.79
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.54
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
124.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-47.0%
Peak to trough
Max drawdown 5Y
-83.6%
Peak to trough
ATR 14
0.17
6.13% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.